Pressroom: Trending Topics

2014

New Research at the 2014 ASCO Annual Meeting

Memorial Sloan Kettering experts are available to comment on research presented at the 2014 annual meeting of the American Society of Clinical Oncology, including research in immunotherapy and targeted therapy, as well as breast, prostate, colorectal, and lung cancers, among others. For more information and to set up interviews or access photos and video, email Caitlin Hool at hoolc@mskcc.org.

May 30, 2014
Landmark Gift of $100 Million from the Marie-Josée and Henry R. Kravis Foundation Will Support Groundbreaking Approach to Precision Oncology

Memorial Sloan Kettering today launched an ambitious initiative to improve cancer care and research through genomic analysis. The new program will reshape clinical trials and speed the translation of novel molecular discoveries into routine clinical practice. The Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO) is named in honor of Marie-Josée and Henry R. Kravis, whose transformative gift of $100 million will make it possible to realize the promise of precision oncology and support the development of new, individualized cancer therapies and diagnostic tools. For more information and to set up interviews or access photos and video, email the Media Staff at mediastaff@mskcc.org.

May 20, 2014
American Society of Clinical Oncology Releases Report on the State of Cancer Care in America

Cancer will become the leading cause of death in the US by 2030 according to a new report, but rising healthcare costs and oncology workforce shortages threaten to limit access to high-quality cancer care.

March 11, 2014
Memorial Sloan Kettering’s Expertise Stands Out at Transplant Meeting

Memorial Sloan Kettering’s achievements in blood and marrow stem cell transplantation are taking center stage at the 2014 BMT Tandem Meeting, a joint conference of the American Society of Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research, which runs from February 26 through March 2. At the meeting, Adult Bone Marrow Transplantation Service Chief Sergio Giralt will assume his role as ASBMT President for the coming year, while Richard O’Reilly, Chair of the Department of Pediatrics and Chief of the Pediatric Bone Marrow Transplant Service, will deliver one of the featured lectures. In addition, Memorial Sloan Kettering physician-scientists Robert Jenq and Yusuke Shono will be presenting two of the six “best abstracts” highlighted at the meeting, which were chosen from a total of 528 abstracts submitted from 30 countries. For more information and to set up interviews, email the Media Staff at mediastaff@mskcc.org.

February 26, 2014
Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study

The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.

February 21, 2014
Recent BMJ Study Should Not Change Mammography Guidelines

A study published by the British Medical Journal questioning the benefit of yearly mammogram screenings has gained momentum in the media, while causing confusion among women and concern among experts in the field, including those at Memorial Sloan Kettering. Our experts agree that annual mammograms starting at age 40 save lives and decrease the likelihood that women will die of breast cancer by at least 25 to 30 percent. Medical oncologist Larry Norton and diagnostic radiologist Carol Lee are available to discuss. For more information and to set up an interview, email the Media Staff at mediastaff@mskcc.org

February 13, 2014
New Breast Surgery Guideline Aims to Spare Women Unnecessary Operations

The new surgical margins guideline takes aim at resolving questions over whether surgery to remove additional normal tissue is needed in breast cancer patients who’ve already had a lumpectomy. Breast surgeon Monica Morrow, who cochaired the committee that created the guideline, is available to comment. For more information and to set up an interview, email the Media Staff at mediastaff@mskcc.org.

February 10, 2014

2013

Science Breakthrough of the Year Is Cancer Immunotherapy

Every year, the editors of Science pick an outstanding scientific achievement as the “Breakthrough of the Year” and this year’s winner – cancer immunotherapy – was pioneered by researchers and clinicians at Memorial Sloan Kettering.

December 20, 2013
Major Developments in Breast Cancer to Be Reported at Annual San Antonio Breast Cancer Symposium

The most influential scientific forum encompassing the full spectrum of breast cancer research, the San Antonio Breast Cancer Symposium, will take place December 10-14. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting.

December 9, 2013
Major Developments in Hematology-Oncology: ASH Annual Meeting

The largest hematology-oncology meeting in the world, the ASH annual meeting, will take place in New Orleans, December 7-10. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting.

December 2, 2013
Amy Robach and the Importance of Annual Mammograms Starting at Age 40

Good Morning America reporter Amy Robach was diagnosed with breast cancer at age 40 after receiving her first mammogram. For Memorial Sloan Kettering experts, the message behind this story bears repeating: Mammograms save lives. Diagnostic radiologist Carol H. Lee and breast surgeons Monica Morrow and Lisa M. Sclafani are available to discuss.

November 13, 2013
Robotic Surgery Safety: A Checklist Approach

A recent report again raises questions about the safety of robotic surgery. Urologic surgeon Vincent Laudone is available to discuss the unique approach MSK has developed to ensure patient safety during robotic procedures.

November 12, 2013
E-cigarettes: Health Experts Warn of Unknown Risks

E-cigarettes are unregulated and the risks associated with their use are unknown. Smoking cessation expert Jack Burkhalter is available to discuss what has become a cause for concern among many health experts.

October 28, 2013
The Cancer Genome Atlas and the Development of Personalized Therapy

Clinical trial design for new cancer therapies has historically been focused on a tumor’s tissue of origin, but a Memorial Sloan Kettering paper supports a new approach: one based on the genomic signature of a tumor rather than its tissue of origin.

October 11, 2013
How Do We Improve Cancer Care in the United States?

The Institute of Medicine recently released its latest comprehensive report on the state of cancer care in the US. Memorial Sloan Kettering’s Mary McCabe and Peter Bach are available to discuss.

October 11, 2013
USPSTF Releases Final Recommendations on Use of Breast Cancer Prevention Drugs

The US Preventive Services Task Force has recommended that breast cancer primary prevention drugs be offered to higher-risk women at low risk of side effects. Memorial Sloan Kettering’s Chief of Breast Cancer Medicine, Clifford Hudis, is available to discuss

September 25, 2013
Major Developments in Radiation Therapy: ASTRO Annual Meeting

The largest radiation oncology event in the world, the ASTRO annual meeting, will take place in Atlanta, September 22-25. Memorial Sloan Kettering radiation oncologists are available to comment on breaking news out of the meeting.

September 20, 2013
Is Breast Cancer Being Overtreated?

Women with breast cancer and relatively favorable prognoses often face treatment choices that balance small gains in outcome with possible negative effects. Medical oncologist Larry Norton and breast surgeon Monica Morrow are available to weigh in on this topic.

August 2, 2013
US Preventive Services Task Force Releases Lung Cancer Screening Recommendations

The US Preventive Services Task Force recommends screening people who are at high risk for lung cancer with annual low-dose CT scans. Thoracic surgeon Nabil Rizk and pulmonologist and epidemiologist Peter Bach are available to discuss the importance of these recommendations.

July 30, 2013
HPV Infection Rate Drops among Vaccinated Girls

HPV vaccination shows a clear benefit in young woman. Gynecologic surgeon Carol Brown is available to discuss this breakthrough.

July 11, 2013
Syndicate content